CME Presentations

CIDP


Presentations


Speakers

  • Todd Levine, MD

    Todd Levine, MD

    Todd Levine, MD

    Medical Director

    Todd Dylan Levine, MD, is the founder and director of the Phoenix Neurological ALS clinic in Phoenix, Arizona, the medical director of HonorHealth Neurology, and an adjunct professor of neurology at Kansas University. Dr Levine conducts extensive research in diseases of the nerve and muscle. He has published his findings in numerous peer-reviewed journals and lectures both nationally and internationally on these disorders. He is one of the founders of Corinthian Reference Labs and a leader in the field of using skin biopsies for diagnosing small fiber neuropathy. He received his medical degree from Duke University in Durham, North Carolina, and completed a residency in neurology and a fellowship in neuromuscular disease at Washington University School of Medicine in St. Louis, Missouri.
  • Roy L. Freeman, MD

    Roy L. Freeman, MD

    Roy L. Freeman, MD

    Professor of Neurology

    Roy Freeman, MD, is a professor of neurology at Harvard Medical School and director of the Center for Autonomic and Peripheral Nerve Disorders in the Department of Neurology at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Dr Freeman’s research encompasses the neurological complications of diabetes and other peripheral neuropathies, neuropathic pain, the autonomic complications of Parkinson’s disease and multiple system atrophy, biomarkers in neurodegenerative diseases, and the diagnosis and treatment of autonomic and peripheral nervous system disorders. He is the principal investigator on National Institutes of Health-funded studies on the neurological complications of diabetes and biomarker development in alpha-synucleinopathies.
  • Jeffrey Allen, MD

    Jeffrey Allen, MD

    Jeffrey Allen, MD

    Associate Professor, Department of Neurology

    Jeffrey Allen, MD, is assistant professor in the Department of Neurology at the University of Minnesota, Minneapolis and adjunct faculty at Northwestern University in Chicago, Illinois. His primary clinical and academic interests are inflammatory neuropathies, including Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN). Dr Allen uses various studies to improve techniques currently used to diagnose inflammatory neuropathy and to identify new and improved treatment methods, including investigating new medications and improving how standard medications are utilized. He is a member of the GBS/CIDP Foundation International Global Medical Advisory Board and on the board of the Inflammatory Neuropathy Consortium (INC).

CME Information

Immune‐mediated Neuropathies: Focus on CIDP


PIM LogoPQH Logo

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

Session 1: Pathophysiological Approach to Therapeutic Interventions

  • Assess the safety, tolerability, and efficacy profiles of treatment options for CIDP

Session 2: Strategies to Address Suboptimal Treatment Response in CIDP

  • Compare assessment tools to measure disease progression and/or treatment response in patients with CIDP
  • Formulate treatment strategies for patients with CIDP who do not adequately respond to first-line treatment options

ACKNOWLEDGEMENT

This activity is supported by educational grants from CSL Behring and Grifols.

TUITION

Complimentary

Jointly Accredited Provider Logo





JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION STATEMENTS

Live Activity
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATE OF RELEASE/EXPIRATION

Live Activity
Thursday, July 18, 2019 from 11:00am – 1:00pm ET.
  • 11:00am - 12:00pm ET: Pathophysiological Approach to Therapeutic Interventions
  • 12:00pm - 1:00pm ET: Strategies to Address Suboptimal Treatment Response in CIDP
Enduring Material

The enduring material will be available from July 18, 2019 to July 18, 2020.

TARGET AUDIENCE

This activity is intended for neurologists, neuromuscular specialists, immunologists, primary care physicians, hospitalists, emergency physicians, advanced practitioners, nurses, and pharmacists.

ESTIMATED TIME TO COMPLETE

This activity consists of two sessions which should take approximately 2 hours to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE / SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE OF CONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty Disclosures

The faculty reported the following financial relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

Name of Faculty or Presenter Reported Financial Relationship
Roy Freeman, MD, MB, ChB
Professor of Neurology
Harvard Medical School
Director, Center for Autonomic and Peripheral Nerve Disorders
Beth Israel Deaconess Medical Center
None
Todd Levine, MD
Medical Director
HonorHealth Neurology
Director
HonorHealth ALS Clinic
Adjunct Professor of Neurology
Kansas University
Consulting Fees: Grifols, Alexion
Jeffrey Allen, MD
Associate Professor, Department of Neurology
University of Minnesota Medical School
Adjunct Faculty
Northwestern University Feinberg School of Medicine
Consulting Fees: CSL Behring, Argenx, Akcea
Fees for Non-CME/CE Services: CSL Behring

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner Reported Financial Relationship
David Howard
Medical Director
PlatformQ Health Education, LLC
None

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Alissa Yost, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:
Please contact the Postgraduate Institute for Medicine at www.pimed.com.

Technical Support:
For any technical issues or issues with your CME Certificate, please contact NeuroSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.